Nerve growth factor: From discovery to development for human use
The evolution opens doors for the treatment of neurotrophic keratitis and beyond.
Dompe's past developments, continual progress in NGF applications
Flavio Mantelli, MD, PhD, Chief Medical Officer at Dompé, shares about the company's role in nerve growth factor (NGF) applications in ophthalmic disease and other human indications.
2 Clarke Drive Cranbury, NJ 08512